Director, Value & Outcomes Liaison

Role Summary

Director, Value & Outcomes Liaison responsible for communicating Celcuity’s clinical, real-world, and health economic evidence to U.S. payer and healthcare decision-making audiences. Build trusted relationships through compliant, evidence-based scientific exchange to support patient access to Celcuity’s oncology therapies. Collaborate across Medical Affairs, Market Access, and HEOR to inform evidence generation priorities, value communication, and payer engagement planning.

Responsibilities

• Serve as a field-based scientific liaison to engage population-health decision makers (PHDMs), including payers, pathway organizations, health systems, research institutions, and policy makers, in clinical, scientific, and health economic exchange for gedatolisib in studied/approved disease areas.
• Support Market Access and Medical Affairs through evidence communication, PHDM insight generation, and cross-functional collaboration to inform access strategies.
• Establish valued relationships with PHDMs within assigned accounts and understand the access landscape including P&T formulary inclusion, pathway development, payer medical policy coverage, and emerging competitive trends.
• Proactively represent the evidence needs of PHDMs to internal stakeholders to guide HEOR planning real-world evidence (RWE) strategies and account planning.
• Identify opportunities for and support collaborative research and data generation partnerships in real-world evidence and outcomes research.
• Maintain deep expertise in oncology disease areas, PHDM landscape dynamics, and HEOR/RWE methodologies.
• Provide internal training and education on health economics and outcomes research concepts to Medical Affairs, Access, and cross-functional teams.
• Contribute scientific expertise and field insights during scientific congresses, advisory boards, and other key engagements (e.g., pre-approval information exchange).
• Other duties as assigned.

Qualifications

• Advanced degree (PhD, PharmD, MD, MPH, or equivalent) in a relevant scientific or health-related discipline.
• Eight plus (8+) years of relevant experience in the pharmaceutical, biotechnology, or healthcare industry, including oncology/hematology and field-based customer-facing roles.
• Demonstrated experience in field-based scientific, PHDM/payer, or HEOR roles with understanding of PHDM/payer evidence needs.
• Solid understanding of HEOR principles, study design, and the U.S. healthcare access environment.
• Demonstrated expertise in HEOR (including observational and pharmacoeconomic research) and value assessment, including RWE studies and pharmacoeconomic models under FDAMA 114.
• Excellent leadership and cross-functional collaboration skills with ability to influence and drive strategy across teams.
• Excellent verbal, written, and presentation skills with strong interpersonal and relationship-building capabilities.
• Highly motivated, self-directed professional who thrives in a fast-paced, collaborative biotech environment.
• Maintain a positive, approachable and professional attitude.

Skills

• Health economics and outcomes research
• Real-world evidence (RWE) generation and analysis
• Pharmacoeconomics and value communication
• Payer and provider engagement
• Cross-functional collaboration and stakeholder management
• Scientific communication and presentations

Education

• Advanced degree as listed in Qualifications (PhD, PharmD, MD, MPH, or equivalent).

Additional Requirements

• None explicitly required beyond qualifications; travel/field presence implied by "field-based" role.